CELZ: Creative Medical Technology Holdings Inc. Average Forecast Price

Corporate company logo of creativemedicaltechnology.com (CELZ)

Creative Medical Technology (CELZ) develops cellular therapies for musculoskeletal and urinary system pathologies, leveraging investment capital to expand its patents and testing. Expected catalysts from immunotherapy remain distant, while R&D costs are already priced into the valuation, which stands at 19.91. This chart of the market price on GURU.Markets is complemented by data on flawless cold-chain logistics for biomaterials, ensuring stable business operations.

creativemedicaltechnology.com - CELZ Consensus Target (period 07/04/2022 - 11/13/2026)

Creative Medical Technology (CELZ) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Quotes creativemedicaltechnology.com|CELZ - Analyst Consensus Forecast
- market capitalization information:
Market Value Creative Medical Technology Holdings Inc.|CELZ - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share Creative Medical Technology|CELZ - Company Net Assets|Market Capitalization to Net Assets creativemedicaltechnology.com|CELZ - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient Creative Medical Technology|CELZ - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio creativemedicaltechnology.com|CELZ - Company Aggregate Debts|Debts to Book Value Creative Medical Technology Holdings Inc.|CELZ - Company Long-Term Debt|Company Current Liabilities Creative Medical Technology|Quick Liquidity Indicator creativemedicaltechnology.com
- financial results and valuation multiples details:
CELZ - Net Profit|Expected Net Profit Creative Medical Technology|CELZ - Price to Earnings Ratio|Future Price to Earnings creativemedicaltechnology.com|CELZ - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Creative Medical Technology Holdings Inc.|CELZ - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Creative Medical Technology|CELZ - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months creativemedicaltechnology.com|CELZ - Earnings per share growth in current year|Expected earnings per share trend next year Creative Medical Technology
- sales revenue and business income indicators:
CELZ - Revenue and Sales Volume|Company Expected Sales Volume creativemedicaltechnology.com|CELZ - P/S Multiple|Forward P/S Multiple Creative Medical Technology Holdings Inc.
General company analysis:CELZ - Creative Medical Technology Holdings, Inc.
Core merchandise of Creative Medical Technology Holdings Inc.

Driven by patents in regenerative medicine, Creative Medical Technology (CELZ) occupies a stable niche within the US biotechnology market. The median analyst price target aggregates investment bank expectations for the asset's value, reflecting the fundamental capitalization potential under current interest rates. While growth in this indicator signals market optimism, investors should weigh these values against the debt load to mitigate risks in the event of a potential overvaluation.

Competitors of Creative Medical Technology

Consensus Target mesoblast.com MESO|Analyst Consensus Forecast LCTX (Lineage Cell Therapeutics, Inc.)|Surrozen Inc (SRZN) - Average Forecast Price|CCEL - Price Target Chart|FBLG: Price Target Chart|LGVN (Longeveron Inc.) - Consensus Target|Forecast Levels Chart BRTX (BioRestorative Therapies, Inc.)